- Joined
- Sep 6, 2017
- Messages
- 30
- Reaction score
- 12
Sorry initially posted in the IM form by mistake. Current fellow here interested in clinical investigation. Curious to know how the authorship order is established for large clinical trials. I have heard that for large multi-center phase III trials, that number of patients enrolled and seniority factor into the authorship. Does that mean that authorship is not pre-established prior to trial activation and is decided at the time of data publication? Do the senior-most authors of the highest enrolling institutions share the first and correspondings for each of the resulting publications? I would imagine that the process depends on variables like industry-sponsored versus cooperative group-based studies, but still would be interested to know some specific examples. I would presume the authorship order for IITs is just up to the PI.